SCHEMBL1675295

SCHEMBL1675295

CN(c1ncc[nH]1)c1ncnc2ccc(-c3ccc(CO)o3)cc12

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CLK4 Q9HAZ1 13/20 0.55
CLK1 P49759 5/20 0.55
DYRK1A Q13627 5/20 0.55
CLK2 P49760 4/20 0.55
DYRK1B Q9Y463 4/20 0.55
EGFR P00533 2/20 0.43
PI4KB Q9UBF8 1/20 0.42
CDK2 P24941 1/20 0.38
LMNA P02545 8/20 0.38
CYP1A2 P05177 8/20 0.38
CYP3A4 P08684 7/20 0.38
ALDH1A1 P00352 6/20 0.38
MAPK1 P28482 5/20 0.38
HSD17B10 Q99714 4/20 0.38
MEN1 O00255 2/20 0.38
KMT2A Q03164 2/20 0.38
TP53 P04637 1/20 0.38
CASP1 P29466 1/20 0.38
CASP7 P55210 1/20 0.38
CYP2D6 P10635 5/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1675115 0.81 CLK1 (0.61) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675201 0.80 CLK4 (0.67) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675047 0.80 CLK4 (0.63) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675230 0.79 CLK4 (0.60) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675224 0.76 CLK4 (0.64) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675083 0.76 CLK4 (0.61) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675160 0.75 CLK4 (0.71) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675298 0.73 CLK4 (0.67) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675212 0.72 CLK4 (0.54) CLK4CLK1DYRK1ACLK2DYRK1B
SCHEMBL1675012 0.71 CLK4 (0.51) CLK4CLK1DYRK1ACLK2DYRK1B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO claimed
WO-2011041655-A1 QUINAZOLIN-4-AMINE DERIVATIVES; AND METHODS OF USE THE UNITED STATES OF AMERICA, AS REPRESENTED BY THE SECRETARY, DEPARTMENT OF HEALTH AND HUMAN SERVICES (US) 2011-04-07 WO disclosed